Monteiro, A F <br/><br/>
Aggressive Inferior Eyelid Basal Cell Carcinoma: Advantage of Neoadjuvant Vismodegib.  [electronic resource] 

 -  Actas dermo-sifiliograficas  Dec 2019 
 - 863-865 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>2173-5778 
<br/><br/><label>Standard No.: </label>10.1016/j.ad.2018.05.022  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged, 80 and over<br/>Anilides--therapeutic use<br/>Carcinoma, Basal Cell--drug therapy<br/>Eyelid Neoplasms--drug therapy<br/>Humans<br/>Male<br/>Neoadjuvant Therapy<br/>Pyridines--therapeutic use